As of 2026-04-19, the Relative Valuation of Intra-Cellular Therapies Inc (ITCI) is (13.46) USD. This relative valuation is based on P/E multiples. With the latest stock price at 131.87 USD, the upside of Intra-Cellular Therapies Inc based on Relative Valuation is -110.2%.
The range of the Relative Valuation is (13.26) - (13.67) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 20.4x | 19.8x |
| Forward P/E multiples | 17.6x - 19.5x | 18.6x |
| Fair Price | (13.26) - (13.67) | (13.46) |
| Upside | -110.1% - -110.4% | -110.2% |
| Date | P/E |